Establish prescribability of statins, ezetimibe and PCSK9-i according to AIFA regulations

Help for the doctor to establish the prescribability of anti-dyslipidemic drugs in Italy
SECTION 1: Guide to the prescription of statins and/or ezetimibe based on risk stratification, according to AIFA NOTE 13.
SECTION 2: Establish the eligibility of patients for therapy with PCSK9 protein inhibitors (evolocumab and alirocumab), based on the provisions of the Italian Medicines Agency (AIFA).